Titan Medical Inc (TMDIF)

[Flenderson]

To an extent they are concerned about the pps level, but it sounds like a 10/1 or 15/1 is there goal. If human studies are not required then it does shorten the timeline and looking around mid 2019 for FDA without human studies. Also, even if human studies are required then another factor involved is how many patients are required. Big difference between 10 or 100 patients as far as timeline is concerned.